Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bioequivalence of Ezetimibe Tablets in Healthy Subjects: A Single-dose and Two-period Crossover Study

NCT04814589 is registered in ClinicalTrials.gov with Cao Yu as lead sponsor.

NCT NCT04814589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04814589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bioequivalence of Ezetimibe Tablets in Healthy Subjects: A Single-dose and Two-period Crossover Study
Lead sponsor
Cao Yu
Phase
Phase 1
Overall status
Unknown status
Start date
March 13, 2021
Completion date
July 31, 2021
Enrollment
96 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

therapeutic equivalency